Spin labels localized either deep in the hydrophobic region or in the aqueous phase are only slowly reduced; however, a spin-labeled analogue of the cationic detergent cetyl trimethyl ammonium bromide which partitions at the interface is rapidly reduced by coupled electron transport. Chemical studies on the reduction and oxidation of the spin label show that loss of signal is due to reduction and not destruction of the label. Also no evidence was found for flip-flop of the label in submitochondrial preparations.
Spin reduction of respiring mitochondria, ffiitoplasts _or inverted submitochondrial preparations is inhibited by rotenone but relatively insensitive to antimycin A and KCN.
Since the midpoint potentials of the spin labels were found to be similar to that of ubiquinone, it is concluded that reducing equivalents of mitochondrial electron transport from this region of the chain are channeled to either membrane interface.
•
• ' ·- The test substance may be a spin label with the convenient property that it can report its own reduction (4) (5) (6) (7) (8) .
By manipulat-_i.on of avaiL.tble r J 2 , by u:::;inq inhibitors specific for particular "sites" and uncouple1:s of respiration, it is sometimes possible to deduce the particular "site" at which the -4-substance is being reduced. On the other hand, the test substance, e.g., a spin label, may have physico-chemical properties ensuring that it will come to rest in a particular region of the mitochondrial structure. When both of these circumstances are realized one can logically conclude that a transfer of reducing equivalents from the electron transport chain to the spin label goes on in the particular region of the mitochondrial structure where the spin labeled molecule is localized. Our paper illustrates the foregoing strategy.
In order to apply this strategy we had to find a spinlabeled substance with the right properties (an analogue of cetyl trimethyl ammonium bromide, CDTAB) to show that after it was intercalated into the mitochondrial structure its signal decayed due to respiratory chain activity, and finally to show by manipulation of this activity that the reductant in the chain most likely to be affecting the spin label was ubiquinone.
MATERIALS AND METHODS

Preparations.
Rat liver mitochondria were prepared in a 0.25 M sucrose, 1 mM Tris Base and 1 mM EDTA medium at pH 7.4 as described in (9) . Mitoplasts were prepared according to (10) . Submitochondrial preparations (SMP) were made following a method described in (11) . Protein concentrations were determined by a standard method (12) .
Spin·Labels. The nitroxide spin-labeled molecules were provided by R.J.
Mehlhorn (of this laboratory) and have the structures shown in figure 2 . The labels T.empo, Tempol, Tempamine, Caprate and CDTAB have a piperidine ni troxide ring whereas 2N3, 2Nll, 7Nl4, Al2NS and A4NS have an oxazolidine nitroxide ring.
Synthesizing procedures for these labels have been described elsewhere (13) (14) (15) .
The mid-point potential (pH 7. ; hydrophilic labels are only appreciably reduced after t.he sample becomes anaerobic, and hydrophobic labels like 7Nl4 are only very slowly reduced.
Interaction of CDTAB with the Chain. Next we tried to localize the "site"
of action of CDTAB in the chemical kinetic scheme. Since CDTAB was reduced in the aerobic steady-state, it was of interest to determine how it was reduced by electron transport. Artificial substrates like ascorbate and durohydroquinone reduce nitroxides chemically and therefore .could not be used to study spin label reduction by electron transport. Mitochondria and mitoplasts metabolizing glutamate-malate and succinate show similar rates in CDTAB reduction. Comparison of CDTAB reduction in mitochondria and SMP (oxidizing NADH and succinate) , are given in Table I .. The mid-point potentials were determined ·as described in Materials and Hethods starting with 100 llM of fully oxidized spin label; that of the piperidine labels (measured both with tempo and.CDTAB) in our test medium was around +60 mV which is slightly above that of ascorbate measured at room temperature and at pH 7.2. The mid-point potential of the oxazolidine labels (measured with 2N3) in our test medium was around +20 mV.
I
Standard potentiometric techniques give the mid-point potential of methylene blue at pH 7 as +10 mV. Using our technique of titrating with ascorbic acid we find the -mid-point potential of methylene blue at pll 7 to be around 0 mV: our technique is therefore valid, yet accurate results will only be obtained where the mid-point potential of the test substance is close
• to that of ascorbic acid. Under our conditions, the mid-point potentials of ·oxazolidine and piperidine labels differ by 40 mV. Using different test conditions, previous woL"kcrs have !>hown (19) that the mid-point potential of the tempo label varies over a considerable range depending on the pH, the concentration and nature of the buffers, and the ionic strength. The closest mid-point potential of a r 0
redox component of mitochondrial electron transport is that of ubiquinone which is +45 mV. We have found in spectrophotometric and EPR studies that ubiquinone in either its fully oxidized or reduced (quinol) state does not interact with CDTAB. However, if the semiquinone free radical species is formed in alkaline ethanolic solutions, it readily reduces CDTAB .
• -12-·
DISCUSSION
This investigation has shown that spin labels can be used to study the channeling of reducing equivalents from mitochondrial electron transport in the mid-point potential range +20 to +60mV. According to. current concepts of electron transport, reducing equivalents are accumulated at various "sites" along the chain of electron carriers ( fig. 1 ). The action of uncouplers to inhibit spin label reduction in the aerobic steady state is consistent with the decreased accumulation of reducing equivalents by the redox components of electron transport which are the electron donors for CDTAB reduction.
Since CDTAB is the label that is reduced fastest in either mitochondria or SMP this indicates that reducing equivalerits are preferentially channelled to the hydrophobic-hydrophilic interface on either side of the membrane.
CDTAB can flip-flop in certain systems, e.g. using the assay method essentially Our results of CDTAB spin reduction in mitoplasts, SHP, and by the semiquinone free radical, similar inhibitor sensitivity, mid-point potential range and a certain degree of structural similarity, suggest that the piperidine label on CDTAB (+60 mV) can accept reducing equivalents from electron transport in the ubiquinone region at each membrane interface. The physical properties expected from the structure of CDTAB suggest that its hydrophobic moiety will locate inside the membrane with the cationic moiety directed toward either surface.
In terms of the strategy outlined in the Introduction, we are led to suggest that ubiquinone must reside wherever the nitroxyl of CDTAB resides, viz. toward either interface. Our results would seem to support some aspects of a recent proposal of Mitchell (21), the "proton motive Q cycle", whereby the mobile uncharged semiquinone form of ubiquinone or "Q" mediates proton translocation across the inner mitochondrial membrane. This result is further reinforced by the finding t.hat the semiquinone constitutes a relatively stable free radical in the mitochondrial inner membrane (22, 23) .
• -14- 
